Evidence map›Paper›PMID 32572711›Full record

ArticleAIDS and behavior2021

Examining Correlates of Pre-ART and Early ART Adherence to Identify Key Factors Influencing Adherence Readiness.

Kyle Gordon, Risa M Hoffman, Gulrez Azhar, Daniel Ramirez, Stefan Schneider, Glenn J Wagner

Abstract read
In one paragraph

Article in AIDS and behavior, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kyle GordonDepartment of Medicine, UCLA, Los Angeles, CA, USA.
Risa M HoffmanDepartment of Medicine, UCLA, Los Angeles, CA, USA.
Gulrez AzharLong Beach Education and Research Consultants, Long Beach, CA, USA.
Daniel RamirezSocial and Economic Wellbeing Division, RAND Corporation, 1776 Main St., Santa Monica, CA, 90401, USA.
Stefan SchneiderSocial and Economic Wellbeing Division, RAND Corporation, 1776 Main St., Santa Monica, CA, 90401, USA.
Glenn J WagnerLong Beach Education and Research Consultants, Long Beach, CA, USA. gwagner@rand.org.ORCID http://orcid.org/0000-0001-9081-3299

Funding

Controlled Evaluation of the Adherence Readiness Program for ART AdherenceR01MH104086 · NIMH · RAND CORPORATION · PI WAGNER, GLENN JOHN · 2015 to 2019
$2.8M
NIMH NIH HHS R01 MH104086NIMH NIH HHS R01MH104086
6 · The paper itself

Abstract

Although current standard of care for HIV typically involves immediate initiation of antiretroviral therapy (ART), most patients can benefit from first assessing adherence readiness and addressing any barriers to optimal adherence. A sample of 176 HIV patients planning to start ART enrolled in a controlled trial of an adherence intervention that was based on the Information Motivation and Behavioral skills (IMB) model of health behavior. We examined correlates of multiple adherence readiness measures, as well as electronically measured early ART adherence, to identify variables most important for readiness to adhere well at the start of treatment. Education level, recency of HIV diagnosis and knowledge and commitment to adherence were found to be associated with both ART readiness and early ART adherence. These findings suggest that resources to support adherence readiness should target more experienced HIV patients, and strive to bolster knowledge and attitudes that reinforce commitment to adherence.

Indexed as

Anti-HIV AgentsHIV InfectionsMedication AdherenceAdultFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMotivationAnti-HIV AgentsAdherenceARTHIVReadiness

Identifiers

PMID32572711
PMCPMC7752814

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.